How Prices for the First 10 Drugs Up for U.S. Medicare Price Negotiations Compare Internationally
Commonwealth Fund 1/4/2024
Highlights
- List retail prices for the 10 selected drugs are, on average, three times higher in the United States than in the other high-income countries.
- Prices after discounts and rebates in the U.S. are higher than almost all prices before discounts and rebates in peer countries, except for Xarelto, leaving significant room for further reductions in negotiation when compared with other countries.
- Switzerland has the second-highest prices for most of the 10 drugs, but U.S. prices remain substantially higher.
